Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Ani Pharmaceuticals (ANIP) over the last 16 years, with Dec 2024 value amounting to -$2.1 million.

  • Ani Pharmaceuticals' Other Working Capital Changes rose 415.60% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 50.47%. This contributed to the annual value of -$2.1 million for FY2024, which is 123.62% down from last year.
  • Per Ani Pharmaceuticals' latest filing, its Other Working Capital Changes stood at -$2.1 million for FY2024, which was down 123.62% from $9.0 million recorded in FY2023.
  • Over the past 5 years, Ani Pharmaceuticals' Other Working Capital Changes peaked at $9.0 million during FY2023, and registered a low of -$2.1 million during FY2024.
  • Moreover, its 3-year median value for Other Working Capital Changes was $798,000 (2022), whereas its average is $2.6 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 1,029.70% in 2023, then tumbled by 123.62% in 2024.
  • Ani Pharmaceuticals' Other Working Capital Changes (MRY) stood at $1.9 million in 2020, then tumbled by 106.81% to -$127,000 in 2021, then surged by 728.35% to $798,000 in 2022, then surged by 1,029.70% to $9.0 million in 2023, then plummeted by 123.62% to -$2.1 million in 2024.
  • Its Other Working Capital Changes stands at -$2.1 million for FY2024, versus $9.0 million for FY2023 and $798,000 for FY2022.